SIRIUS is setting new standards in molecular identification, enabling the elucidation of previously uncharted compounds, and making a valuable contribution to both science and industry. Here you’ll find a variety of posts showcasing how SIRIUS advances metabolomics and molecular identification.

Discoveries

Explore how research groups are leveraging the power of SIRIUS to elevate their metabolomics data analysis across various fields.

Research Projects

Our commitment is to continue improving SIRIUS and shaping the future of metabolomics research by initiating new research projects.

Press Releases

Read official announcements and statements from Bright Giant, covering partnerships and company milestones.

SIRIUS Background

Learn more about the science and concepts behind SIRIUS to get a deeper understanding of its capabilities.

Application Notes

Learn practical strategies from our real-world applications alongside detailed information on how to get the most out of SIRIUS in your analyses.

Tutorials

Read our step-by-step guides to help you master SIRIUS features and workflows.

Collaborations

Collaborations with leading research groups and industry partners to integrate the latest scientific advancements into SIRIUS for your analyses.

Discoveries: Explore how research groups are leveraging the power of SIRIUS to elevate their metabolomics data analysis across various fields, including drug discovery, diagnostics, food industry, environmental toxicology, and materials science. For an extensive list of discoveries, click here.
Tutorials: Read our step-by-step guides to help you master SIRIUS features and workflows.
Application Notes: Learn practical strategies from our real-world applications alongside detailed information on how to get the most out of SIRIUS in your analyses.
Research Projects: Our commitment is to continue improving SIRIUS and shaping the future of metabolomics research by initiating new research projects.
Background: Learn more about the science and concepts behind SIRIUS to get a deeper understanding of its capabilities.
Press Releases: Read official announcements and statements from Bright Giant, covering partnerships and company milestones.
Collaborations: The SIRIUS team partners with leading research groups and industry partners to integrate the latest scientific advancements, ensuring SIRIUS remains the most versatile and powerful tool for your analyses.

Discoveries

Exploring the Chemical Dark Matter of the Amazon’s Iron Caves with SIRIUS

Deep within the aphotic zones of the Amazon’s ferruginous caves, a hidden world of microbial “dark matter” holds immense potential as a source for pharmacological innovation. A pioneering metabolomic survey of these extreme environments isolates rare bacterial genera that thrive in these iron-rich landscapes. They use SIRIUS to identify and classify chemical features, including potent cyclopeptides demonstrating growth inhibition against cancer cell lines.

Franziska Hufsky 2026-04-23 No Comments

Discoveries

Revealing the Hidden Burden of Offshore Discharges with SIRIUS

Offshore produced water discharges introduce over 240 billion liters of complex chemical mixtures into the marine environment annually. In a case study using produced water from North Sea offshore oil platforms, researchers demonstrated that traditional monitoring significantly underestimates the persistence of discharged chemicals. They introduce a novel analytical framework using advanced non-target analysis and computational workflows, including SIRIUS to highlight a significant “hidden burden” of persistent pollutants.

Franziska Hufsky 2026-03-19 No Comments

Discoveries

Environmental and Maternal Drivers of the Infant Gut Metabolome Revealed Using SIRIUS

The maturation of the gut microbiome during the first six months of life is a foundational process, playing a key role in metabolic programming and training of the immune system, but these patterns remain critically underexplored in populations from low- and middle-income countries. To address this gap, an observational, longitudinal study profiled the developing gut microbiome and metabolome in Bangladesh using a multi-omics approach. Systematic classification and metabolite annotation was achieved using SIRIUS. The overall aim was to understand how maternal and environmental factors—specifically delivery mode, maternal milk composition, and household water treatment—shape this foundational postnatal development.

Franziska Hufsky 2026-02-24 No Comments

Discoveries

Reducing PFAS Emissions: Efficacy of Abatement Systems at Fluoropolymer Plants Investigated Using SIRIUS

Fluoropolymer production plants are an obvious source for PFAS emission into our environment. They have invested in abatement systems to curtail the emission of PFAS but their efficacy has not been reported in peer-reviewed literature. A recent study investigates their efficacy and reveals a more complex emission profile than previously understood. In a suspect screening approach using SIRIUS, they detected a homologous series of previously overlooked polymerization byproducts.

Franziska Hufsky 2025-12-18 No Comments

Discoveries

Decoding the influence of gut microbiota on drug efficacy with SIRIUS

In pharmacology, one of the most significant challenges is the variability in how patients respond to the same drug. While factors like genetics and lifestyle are known to play a role, emerging research points to a hidden player: the human gut microbiota. This vast community of trillions of microbes is an active participant in our health, influencing everything from nutrient absorption to the efficacy of our medications. Using advanced computational tools like SIRIUS to analyze mass spectrometry data, researchers investigated how gut microbiota alter the chemical structure of GPCR drugs.

Franziska Hufsky 2025-12-02 No Comments

Discoveries

SIRIUS in the Jena Experiment: It’s a Battle for Resources, Not a Break from Pests

In a biodiverse ecosystem, it’s often assumed that plants have safety in numbers—that a mix of species will confuse pests and dilute disease pressure, allowing individual plants to save energy on defences and focus on growth. But is this ecological truism always the case? A recent study from the long-running Jena Experiment uses untargeted metabolomics and SIRIUS for feature annotation and compound class prediction. They found that for many plants in a diverse community it is less about relaxing their defences and more about adapting to intense competition for light and nutrients.

Franziska Hufsky 2025-11-18 No Comments

Collaborations

mzio GmbH and Bright Giant GmbH Announce Seamless Integration Between mzmine and SIRIUS

mzio GmbH and Bright Giant GmbH announce a new integration between mzmine and SIRIUS. This collaboration enables researchers to launch SIRIUS analysis directly from mzmine feature tables, automating result handling and eliminating the need for manual data transfer to streamline small molecule discovery workflows.

Franziska Hufsky 2025-11-11 No Comments

Discoveries

SIRIUS in Space: The ISS metabolome

As we prepare for longer human missions beyond Earth, understanding the invisible ecosystems of space habitats has become critical for astronaut health. The International Space Station (ISS) is not just a home and laboratory—it is also a closed microbial and chemical environment unlike anything on Earth. This study mapped the ISS microbiome and metabolome in unprecedented detail, uncovering its vast chemical “dark matter” using SIRIUS.

Franziska Hufsky 2025-11-11 No Comments

Collaborations

Going Barcode-Free: Screening Massive Small Molecule Libraries for Early Drug Discovery

Our recent study co-authored by researchers at Bright Giant, FSU Jena, Leiden University and Oncode Institute introduces a major leap forward in affinity selection screening for early drug discovery: Self-Encoded Libraries. Our approach uses advanced mass spectrometry to screen hundreds of thousands of small molecules in a single experiment, bypassing the significant limitations of traditional high-throughput screening as well as affinity selection with barcoded libraries. It allows drug discovery teams to identify high-affinity drug candidates faster, more affordably, and against targets previously inaccessible to common screening methods.

Franziska Hufsky 2025-11-04 No Comments